Evidence map›Paper›PMID 28744336›Full record

Trial reportOxidative medicine and cellular longevity2017

Oxidative Phosphorylation System in Gastric Carcinomas and Gastritis.

René G Feichtinger, Daniel Neureiter, Tom Skaria, Silja Wessler, Timothy L Cover, Johannes A Mayr, Franz A Zimmermann, Gernot Posselt, Wolfgang Sperl, Barbara Kofler

Open access · hybridAbstract readClinical Trial
In one paragraph

Trial report in Oxidative medicine and cellular longevity, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

René G FeichtingerLaura-Bassi Centre of Expertise, Research Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, Paracelsus Medical University, 5020 Salzburg, Austria.ORCID 0000-0002-4215-8258
Daniel NeureiterInstitute of Pathology, Paracelsus Medical University, 5020 Salzburg, Austria.ORCID 0000-0001-9155-5762
Tom SkariaLaura-Bassi Centre of Expertise, Research Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, Paracelsus Medical University, 5020 Salzburg, Austria.
Silja WesslerDivision of Molecular Biology, Department of Microbiology, Paris-Lodron University, 5020 Salzburg, Austria.
Timothy L CoverDepartment of Medicine and Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine and Veterans Affairs Tennessee Valley Healthcare System, Nashville, TN 37232, USA.
Johannes A MayrDepartment of Pediatrics, Paracelsus Medical University, 5020 Salzburg, Austria.ORCID 0000-0001-6970-336X
Franz A ZimmermannDepartment of Pediatrics, Paracelsus Medical University, 5020 Salzburg, Austria.ORCID 0000-0002-5380-6783
Gernot PosseltDivision of Molecular Biology, Department of Microbiology, Paris-Lodron University, 5020 Salzburg, Austria.
Wolfgang SperlDepartment of Pediatrics, Paracelsus Medical University, 5020 Salzburg, Austria.
Barbara KoflerLaura-Bassi Centre of Expertise, Research Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, Paracelsus Medical University, 5020 Salzburg, Austria.
Paracelsus Medical University · ATUniversity of Salzburg · ATVanderbilt University · US

Funding

Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Role of Iron and B-Catenin Activation in Gastric CarcinogenesisP01CA116087 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Kevin L Schey · 2009 to 2026
$27.5M
Structure-function analysis of H. pylori VacAR01AI039657 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI TIMOTHY L COVER · 1996 to 2026
$8.3M
Pathogenesis of Helicobacter pylori infectionI01BX000627 · VA · VETERANS HEALTH ADMINISTRATION · PI COVER, TIMOTHY L · 2011 to 2018
–
BLRD VA I01 BX000627NCI NIH HHS P01 CA116087NIAID NIH HHS R01 AI039657NIDDK NIH HHS P30 DK058404
6 · The paper itself

Abstract

Switching of cellular energy production from oxidative phosphorylation (OXPHOS) by mitochondria to aerobic glycolysis occurs in many types of tumors. However, the significance of this switching for the development of gastric carcinoma and what connection it may have to

Indexed as

Gene Expression Regulation, EnzymologicGene Expression Regulation, NeoplasticHelicobacter pyloriOxidative PhosphorylationElectron Transport Complex IFemaleGastritisHelicobacter InfectionsHumansMaleNeoplasm ProteinsStomach NeoplasmsElectron Transport Complex INeoplasm Proteins

Identifiers

PMID28744336
PMCPMC5506471
OpenAlexW2733810100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.